National Pension Service Decreases Position in Cencora, Inc. (NYSE:COR)

National Pension Service lessened its holdings in Cencora, Inc. (NYSE:COR) by 1.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 302,508 shares of the company’s stock after selling 5,411 shares during the quarter. National Pension Service owned 0.16% of Cencora worth $67,967,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in the business. Advisor OS LLC raised its position in Cencora by 55.8% in the 4th quarter. Advisor OS LLC now owns 2,243 shares of the company’s stock worth $504,000 after purchasing an additional 803 shares during the period. FourThought Financial Partners LLC purchased a new position in Cencora in the 4th quarter worth $215,000. Quartz Partners LLC raised its position in Cencora by 10.4% in the 4th quarter. Quartz Partners LLC now owns 8,853 shares of the company’s stock worth $1,989,000 after purchasing an additional 831 shares during the period. Edge Capital Group LLC purchased a new position in shares of Cencora in the fourth quarter valued at about $2,832,000. Finally, Crestwood Advisors Group LLC increased its position in shares of Cencora by 18.3% in the fourth quarter. Crestwood Advisors Group LLC now owns 1,256 shares of the company’s stock valued at $282,000 after acquiring an additional 194 shares during the period. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on the stock. Barclays boosted their price objective on shares of Cencora from $263.00 to $290.00 and gave the company an “overweight” rating in a research report on Thursday, November 7th. UBS Group boosted their price objective on shares of Cencora from $275.00 to $285.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. JPMorgan Chase & Co. boosted their price objective on shares of Cencora from $289.00 to $301.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Mizuho assumed coverage on shares of Cencora in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $280.00 price objective on the stock. Finally, Evercore ISI boosted their price objective on shares of Cencora from $270.00 to $280.00 and gave the company an “outperform” rating in a research report on Thursday, February 6th. Two investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $277.90.

Insider Transactions at Cencora

In other news, EVP Silvana Battaglia sold 1,678 shares of the company’s stock in a transaction that occurred on Friday, December 20th. The shares were sold at an average price of $228.72, for a total value of $383,792.16. Following the transaction, the executive vice president now owns 20,329 shares in the company, valued at approximately $4,649,648.88. This represents a 7.62 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 10.80% of the company’s stock.

Cencora Trading Down 0.8 %

NYSE:COR opened at $248.71 on Friday. Cencora, Inc. has a one year low of $214.77 and a one year high of $262.26. The company has a debt-to-equity ratio of 16.40, a current ratio of 0.92 and a quick ratio of 0.54. The company’s 50-day simple moving average is $240.74 and its 200 day simple moving average is $237.66. The firm has a market capitalization of $48.23 billion, a P/E ratio of 35.38, a PEG ratio of 1.31 and a beta of 0.49.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $3.73 EPS for the quarter, topping the consensus estimate of $3.50 by $0.23. Cencora had a net margin of 0.46% and a return on equity of 328.62%. As a group, analysts forecast that Cencora, Inc. will post 15.37 EPS for the current fiscal year.

Cencora Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Friday, February 14th will be paid a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 0.88%. The ex-dividend date is Friday, February 14th. Cencora’s payout ratio is currently 31.29%.

Cencora Company Profile

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.